Aprotinin in spine surgery: Review of the literature

Orthopedics

Volumn 27, Issue 6 SUPPL., 2004, Pages

  Bitan, Fabien David ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; ERYTHROPOIETIN;

ANTERIOR SPINE FUSION; BLEEDING; BLOOD TRANSFUSION; CAUTERIZATION; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; PATIENT POSITIONING; PREOPERATIVE EVALUATION; SCOLIOSIS; SHORT SURVEY; SPINE MALFORMATION; SPINE SURGERY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM;

ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; HUMANS; SPINE;

EID: 3142716196     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Lentschener C, Cottin P, Bouaziz H, et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg. 1999; 89:590-597.
2. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine. 2001; 26:1152-1156.
3. Karapurkar A, Kudalkar A, Naik L. Aprotinin to reduce perioperative blood loss in scoliosis surgery. Indian J Anaesth. 2002; 46:378-380.
4. Cole JW, Murray DJ, Snider RJ, et al. Aprotinin reduces blood loss during spinal surgery in children. Spine. 2003; 28:2482-248